Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carducci

Showing results (351-360 of 386) with videos related to

Pageof 39
Sort By:
Cancer Research|April 15, 1997
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferJ W Simons, E M Jaffee, C E Weber, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerMatthew P Deek, Kekoa Taparra, Dyda Dao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
The Prostate|April 15, 2024
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical modelsSumer Jasmine, Adel Mandl, Timothy E G Krueger, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomicsPhilip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
The New England Journal of Medicine|September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.
Pageof 39

Showing results (351-360 of 386) with videos related to

Sort By:
Pageof 39
Cancer Research|April 15, 1997
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transferJ W Simons, E M Jaffee, C E Weber, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerMatthew P Deek, Kekoa Taparra, Dyda Dao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate CancerSusan Halabi, Qian Yang, Akash Roy, et al.
The Prostate|April 15, 2024
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical modelsSumer Jasmine, Adel Mandl, Timothy E G Krueger, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomicsPhilip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
The New England Journal of Medicine|September 4, 2014
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmmanuel S Antonarakis, Changxue Lu, Hao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton, James R Berenson, Jean-Jacques Body, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
Cancer Research|October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transferJ W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignanciesW G Nelson, J W Simons, B Mikhak, et al.
Pageof 39